JNJ-17299425

· Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-17299425, covering 2013-05-01 to 2013-05-01. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of JNJ-17299425 in Participants With Traumatic Brain Injury [Phase 2]

See pricing